Topical Corticosteroids Sales Market Share will Observe Substantial Growth by 2027 | Size | Share | Growth | Outlook

Seattle, WA -- (SBWire) -- 12/05/2019 --Topical corticosteroids are man-made corticosteroid therapies that are used for treating skin-related diseases such as rash, psoriasis, itching, dermatitis, and eczema. Topical corticosteroids have superior anti-inflammatory actions and are also effective in suppressing the immune responses. They have side-effects such as itching, irritation, and dryness. Moreover, long-term usage of topical corticosteroids can also lead to the risk of infection, loss of skin tone, and deterioration of skin cells. They are available in the form of a solution, oil, foam, ointment, gel, spray, and shampoo.

The rising cases of skin disease due to various environmental factors and other factors are expected to drive the market growth of topical corticosteroids. According to the World Psoriasis Day consortium, 125 million people worldwide—2 to 3 percent of the total population—have psoriasis.

Fill the sample form to gain deeper insights on Topical Corticosteroids Sales market: https://www.stratagemmarketinsights.com/sample/6832

Moreover, the increasing launch of the advanced drug for the treatment of various skin diseases by the major player is further expected to boost the market growth of topical Corticosteroids. For instance, in February 2019, Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the launch of LEXETTE™ (halobetasol propionate) Foam 0.05% in the United States. Halobetasol foam is a new formulation of halobetasol, a potent topical corticosteroid indicated for the treatment of plaque psoriasis in adult patients.

From the geographical perspective, North America is expected to gain significant growth over the forecast period and this can be attributed to the high prevalence of psoriasis among American populations. According to the American Academy of Dermatology Association, approximately 7.5 million people in the United States have psoriasis and Rosacea is a common skin disease that affects 16 million Americans. Hence, the demand for topical corticosteroids is high in the region.

Key Developments:

- In May 2018, Encore Dermatology Inc. launched its new topical product, Impoyz Cream, indicated for the treatment of moderate to severe plaque psoriasis in patients 18 years of age or older. Impoyz Cream is the only FDA-approved high-potency topical corticosteroid with 0.025% clobetasol propionate.

- In February 2016, the FDA has approved Sernivo Spray, 0.05%, a topical steroid for treating mild-to-moderate psoriasis in patients aged 18 years and older, according to a press release from Dr. Reddy's Laboratories.

- In April 2019, MorphoSys and Galapagos have commenced a Phase II clinical trial, in alliance with Novartis Pharma, to assess subcutaneous MOR106 in combination with topical corticosteroids to treat moderate to severe atopic dermatitis.

- In April 2014, Sandoz announced the US market introduction of its calcipotriene and betamethasone dipropionate ointment, the first generic version of Leo Pharma's Taclonex® Ointment. Calcipotriene and betamethasone dipropionate ointment is a vitamin D analogue and corticosteroid combination product indicated for the topical treatment of psoriasis vulgaris in adults 18 years of age and older.

Global Topical Corticosteroids market competition by top manufacturers/players, with Topical Corticosteroids sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including;

--AstraZeneca plc
--GlaxoSmithKline plc
--Merck & Co., Inc.
--Pfizer Inc.
--Sandoz AG (Novartis AG)
--Sanofi S.A.
--Actimis Pharmaceuticals
--Valeant Pharmaceuticals
--Almirall, S.A
--Zylera Pharmaceuticals

Here you can also read the top 10 companies analysis of Topical Corticosteroids Market... Just click the link: https://www.stratagemmarketinsights.com/quiry/6832

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into;

By Type of Formulation:
--Ointments
--Creams
--Others

By Type of Potency Class:
--Ultra High
--High
--Moderate
--Low

By Treatment:
--Contact Dermatitis
--Insect Stings
--Psoriasis
--Eczema
--Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Topical Corticosteroids for each application, including;

--Hospitals
--Dermatology Clinics
--Pharmacies
--Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Buy Topical Corticosteroids Market Exclusive Report @ https://www.stratagemmarketinsights.com/cart/6832

About Stratagem Market Insights
Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with an cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. Our reports cover various end-use industries such as Aerospace and Defense, Agriculture, Food and Beverages, Automotive, Chemicals and Materials, Consumer Goods and Retail, Electronics, Energy, Mining, and Utilities, Pharmaceuticals, Manufacturing and Construction, Services, and Healthcare, and ICT.